The BRCA1 3450del4 founder mutation accounts for 11.5% of unselected ovarian cancers and represents 73% of BRCA mutations [23] and 1.6% of unselected breast cancers in Bogota [22]. This evidence concerns the gene BRCA1 and breast carcinoma.